Skip to main content
. Author manuscript; available in PMC: 2023 Apr 4.
Published in final edited form as: Cancer Prev Res (Phila). 2022 Oct 4;15(10):689–700. doi: 10.1158/1940-6207.CAPR-22-0013

Table 2.

Baseline characteristics of healthcare providers

Provider Characteristics Total (N=45)
Age, years
 Mean (SD) 44 (13.3)
Gender, N (%)
 Male 12 (27)
 Female 33 (73)
Race/ethnicity, N (%)
 Non-Hispanic White 31 (69)
 Non-Hispanic Black 4 (9)
 Hispanic 4 (9)
 Asian 5 (11)
 Other Race 1 (2)
Medical specialty, N (%)
 Internal medicine 30 (67)
 Family medicine 4 (9)
 Gynecology 6 (13)
 Other 5 (11)
Number of years since completed training, N (%)
 Have not yet finished training 10 (22)
 <5 8 (18)
 5-10 6 (13)
 11-15 4 (9)
 16-20 8 (18)
 >20 9 (20)
Willingness to try new technology (range, 0-100)
 Mean (SD) 78.2 (19.6)
Number of years using EHR, N (%)
 <5 8 (18)
 5-10 25 (56)
 11-15 10 (22)
 16-20 2 (4)
Ever used the Gail model, N (%)
 Yes 20 (44)
  Used the Gail model for which patients (multiple responses)
   Women age 60 years or older 4 (20)
   Women with a breast cancer family history 10 (50)
   Women who may be at higher than average risk for breast cancer 10 (50)
   I do not regularly use breast cancer risk assessment tools 7 (35)
 No 25 (56)
  Reasons for not using the Gail model (multiple responses)
   I do not see patients in whom breast cancer risk calculation is indicated 1 (4)
   I do not have enough time with my patients to use breast cancer risk assessment tools 6 (24)
   I do not think that the results of breast cancer risk assessment tools would change my management 4 (16)
   I am not sufficiently familiar with breast cancer risk assessment tools 20 (80)
Ever prescribed chemoprevention, N (%)
 Yes 11 (24)
  About how many patients
   1-5 11 (100)
 No 33 (73)
  Reasons for not prescribing chemoprevention (multiple responses)
   I have not identified a patient in whom chemoprevention was indicated 8 (24)
   I do not believe that chemoprevention benefits most women who are eligible to receive it 0
   I am not comfortable prescribing chemoprevention 18 (55)
   I do not have time to discuss chemoprevention with my patients 4 (12)
   I would prefer to refer my high-risk patients to a specialist to discuss chemoprevention 22 (66)
Mean confidence in risk communication [range, 1 - 6] (SD) 3.80 (0.10)